COMPLEMENT-MEDIATED RENAL DISEASES

Clinical trials for COMPLEMENT-MEDIATED RENAL DISEASES explained in plain language.

Never miss a new study

Get alerted when new COMPLEMENT-MEDIATED RENAL DISEASES trials appear

Sign up with your email to follow new studies for COMPLEMENT-MEDIATED RENAL DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug trial aims to protect kidneys from immune system attack

Disease control Not yet recruiting

This study is testing an investigational drug called LP-005 for people with kidney diseases caused by an overactive part of the immune system called the complement system. The drug is given as an injection in addition to standard treatment. Researchers will measure if it reduces …

Matched conditions: COMPLEMENT-MEDIATED RENAL DISEASES

Phase: PHASE2 • Sponsor: Longbio Pharma • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

COMPLEMENT-MEDIATED RENAL DISEASES

Get alerted when new COMPLEMENT-MEDIATED RENAL DISEASES trials appear

New drug trial aims to protect kidneys from immune system attack